GlassScriptPhysician profile
Marie U James
NPI 1871650051
$817.31
in general payments reported to CMS, 2019-2025
16 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.61 · 2022: $46.69 · 2023: $420 · 2024: $189 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651 · Education: $95.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $651.01 |
| Education | $95.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $138.09 | 2024-2025 | |
| Incyte Corporation | $122.80 | 2021-2024 | Jakafi |
| Gt Medical Technologies, INC | $94.18 | 2023 | Gammatile |
| Lilly USA, LLC | $78.16 | 2023-2025 | Jaypirca |
| Astellas Pharma US INC | $53.42 | 2023-2024 | Xospata, Cresemba |
| Cti Biopharma Corp. | $52.66 | 2023 | Vonjo |
| Celgene Corporation | $43.36 | 2022-2023 | Reblozyl |
| Blueprint Medicines Corporation | $32.22 | 2024 | Ayvakit |
| Novartis Pharmaceuticals Corporation | $29.32 | 2023 | |
| Pharmaessentia USA Corporation | $28.26 | 2024 | Besremi |
| Daiichi Sankyo INC. | $27.26 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $24.85 | 2023 | Calquence |
| Servier Pharmaceuticals LLC | $24.62 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $24.27 | 2023 | Epkinly, Imbruvica |
| Janssen Biotech, INC. | $22.17 | 2023 | Imbruvica |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beigene USA, INC. | $21.67 | 2024 | Brukinsa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marie James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.